Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA).

Authors

Destie Provenzano, George Washington University
Kevin Rao
Gizem Cifter, George Washington University
Neil Taunk
Benjamin Fischer-Valuck
Alexander Lin
Mehrdad Sarfaraz, George Washington University
Hamid Aghdam, George Washington University
Martin Ojong-Ntui, George Washington University
Murray H. Loew, George Washington University
Sharad Goyal, George Washington University
Yuan James Rao, George Washington University

Document Type

Journal Article

Publication Date

6-1-2021

Journal

Brachytherapy

DOI

10.1016/j.brachy.2021.04.005

Comments

Online ahead of print

APA Citation

Provenzano, D., Rao, K., Cifter, G., Taunk, N., Fischer-Valuck, B., Lin, A., Sarfaraz, M., Aghdam, H., Ojong-Ntui, M., Loew, M. H., Goyal, S., & Rao, Y. J. (2021). Adverse events of after-loading high dose rate brachytherapy reported to the United States Food and Drug Administration (FDA).. Brachytherapy, (). http://dx.doi.org/10.1016/j.brachy.2021.04.005

Peer Reviewed

1